D Zhang1, J Chen1, J Wang1, S Gong1, H Jin1, P Sheng1, X Qi1, L Lv1, Y Dong1,2, L Hou1. 1. Department of Neurosurgery, Shanghai Institute of Neurosurgery, PLA Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China. 2. Department of Neurosurgery, Neuroscience Center, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Abstract
BACKGROUND/ OBJECTIVES: Data regarding the relationships between body mass index (BMI) and brain tumors are inconsistent, especially for the commonly seen gliomas and meningiomas. Therefore, we conducted a dose-response meta-analysis to unravel the issue. SUBJECTS/ METHODS: Cochrane Library, PubMed and Embase were searched for pertinent case-control and cohort studies updated to November 2014. Dose-response and quantitative analysis were conducted with random-effect model. RESULTS: Sixteen studies were included, containing 3 887 156 participants and 11 614 cases. In categorical analysis for the relationships between abnormal weight and BMI, the summary risk ratio (RR) of brain tumors was 1.34 (95% confidential interval (CI), 1.15-1.56) for obesity, 1.12 (95% CI, 1.05-1.19) for overweight and 0.77 (95% CI, 0.64-0.93) for underweight; the summary RR of gliomas was 1.13 (95% CI, 1.02-1.26) for overweight and 0.71 (95% CI, 0.58-0.88) for underweight; the summary RR of meningiomas was 1.48 (95% CI, 1.30-1.69) for obesity and 1.18 (95% CI, 1.07-1.31) for overweight. In dose-response analysis, for every 5 kg/m(2) increment of BMI, the summary RR was 1.13 (95% CI, 1.07-1.20) for overall brain tumors, 1.07 (95% CI, 0.97-1.19) for gliomas and 1.19 (95% CI, 1.14-1.25) for meningiomas. CONCLUSIONS: Excess weight was associated with increased risk of brain tumors and meningiomas but not with gliomas. Selective screening for brain tumors among obesity, especially for the females, might be more instructive.
BACKGROUND/ OBJECTIVES: Data regarding the relationships between body mass index (BMI) and brain tumors are inconsistent, especially for the commonly seen gliomas and meningiomas. Therefore, we conducted a dose-response meta-analysis to unravel the issue. SUBJECTS/ METHODS: Cochrane Library, PubMed and Embase were searched for pertinent case-control and cohort studies updated to November 2014. Dose-response and quantitative analysis were conducted with random-effect model. RESULTS: Sixteen studies were included, containing 3 887 156 participants and 11 614 cases. In categorical analysis for the relationships between abnormal weight and BMI, the summary risk ratio (RR) of brain tumors was 1.34 (95% confidential interval (CI), 1.15-1.56) for obesity, 1.12 (95% CI, 1.05-1.19) for overweight and 0.77 (95% CI, 0.64-0.93) for underweight; the summary RR of gliomas was 1.13 (95% CI, 1.02-1.26) for overweight and 0.71 (95% CI, 0.58-0.88) for underweight; the summary RR of meningiomas was 1.48 (95% CI, 1.30-1.69) for obesity and 1.18 (95% CI, 1.07-1.31) for overweight. In dose-response analysis, for every 5 kg/m(2) increment of BMI, the summary RR was 1.13 (95% CI, 1.07-1.20) for overall brain tumors, 1.07 (95% CI, 0.97-1.19) for gliomas and 1.19 (95% CI, 1.14-1.25) for meningiomas. CONCLUSIONS: Excess weight was associated with increased risk of brain tumors and meningiomas but not with gliomas. Selective screening for brain tumors among obesity, especially for the females, might be more instructive.
Authors: Eunsuk Lee; James Grutsch; Victoria Persky; Roberta Glick; Juliana Mendes; Faith Davis Journal: Int J Cancer Date: 2006-09-01 Impact factor: 7.396
Authors: Steven C Moore; Preetha Rajaraman; Robert Dubrow; Amy S Darefsky; Corinna Koebnick; Albert Hollenbeck; Arthur Schatzkin; Michael F Leitzmann Journal: Cancer Res Date: 2009-10-06 Impact factor: 12.701
Authors: M Wiedmann; C Brunborg; K Lindemann; T B Johannesen; L Vatten; E Helseth; J A Zwart Journal: Br J Cancer Date: 2013-06-18 Impact factor: 7.640
Authors: Ivo S Muskens; Anna H Wu; Jacqueline Porcel; Iona Cheng; Loïc Le Marchand; Joseph L Wiemels; Veronica Wendy Setiawan Journal: Neuro Oncol Date: 2019-03-18 Impact factor: 12.300
Authors: Markus K H Wiedmann; Cathrine Brunborg; Antonio Di Ieva; Kristina Lindemann; Tom B Johannesen; Lars Vatten; Eirik Helseth; John A Zwart Journal: Neuro Oncol Date: 2017-07-01 Impact factor: 12.300
Authors: Svenja Offer; Julien A Menard; Julio Enríquez Pérez; Kelin G de Oliveira; Vineesh Indira Chandran; Maria C Johansson; Anna Bång-Rudenstam; Peter Siesjö; Anna Ebbesson; Ingrid Hedenfalk; Pia C Sundgren; Anna Darabi; Mattias Belting Journal: J Exp Clin Cancer Res Date: 2019-06-07
Authors: Martina Gažarová; Maroš Bihari; Marta Lorková; Petra Lenártová; Marta Habánová Journal: Int J Environ Res Public Health Date: 2022-09-29 Impact factor: 4.614